Bajaj et al reported a bedside tool for predicting 30-day survival for a patient with infection-related acute-on-chronic liver failure (ACLF). This is based on the number of organ failures present, similar to the multiorgan failure (MOF) scores in critical care. The authors are from multiple institutions in the United States and Canada belonging to the North American Consortium for the Study of End-stage Liver Disease (NACSELD).